CXCR4(chemokine (C-X-C motif) receptor 4)
基因简称(symbol)
基因种类(locus group)
同源简称(alias symbol)
基因家族代码(gene_family_id)
omim代码
entrez码
vega基因码
ensembl基因码
基因家族(gene family)
refseq数据库代号
更多...
基因种类(locus_type)
基因名称状态(status)
location_sortable
同源基因名称(alias name)
基因名称批准使用时间(date_approved_reserved)
基因简称更名时间(date_symbol_changed)
基因名称更名时间(date_name_changed)
更新时间(date_modified)
ucsc码
ena
ccds数据码
uniprot数据码
pubmed代码
mgd码
rgd码
生命科学数据库(lsdb)
更新时间(date modified)
cosmic
mirbase
基因曾用简称(prev symbol)
基因曾用名称(prev name)
homeodb
cosmic
snornabase
bioparadigms slc
orphanet
假基因信息(pseudogeneorg)
horde id
merops
imgt
iuphar
kznf基因类别
mamit-trnadb
cd
LncRNA数据库
酶代码
中间纤维数据库
收起
This gene encodes a CXC chemokine receptor specific for stromal cell-derived factor-1. The protein has 7 transmembrane regions and is located on the cell surface. It acts with the CD4 protein to support HIV entry into cells and is also highly expressed in breast cancer cells. Mutations in this gene have been associated with WHIM (warts, hypogammaglobulinemia, infections, and myelokathexis) syndrome. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]
[中文简述(自动翻译):] 这个基因编码特异于基质细胞衍生因子-1的CXC趋化因子受体。该蛋白质具有7跨膜区和位于细胞表面上。它与CD4蛋白作用以支持HIV进入细胞中，并且也高度在乳腺癌细胞中表达。在这种基因突变与WHIM（疣，低丙球蛋白血症，感染，和myelokathexis）综合征。备用转录剪接变体，编码不同同种型，已经表征。 [由RefSeq的，2008年7月提供]
CXCR4基因的碱基突变：
显示全部snp
rs1112156
rs2228014
rs2471859
rs2680880
rs3806501
rs3840463
rs6712264
rs11323000
rs11682928
rs13383139
rs17848045
rs17848046
rs17848047
rs17848048
rs17848049
rs17848050
rs17848052
rs17848053
rs17848054
rs17848056
rs17848059
rs17848060
rs17848061
rs17848384
rs17848385
rs56400844
rs74348454
rs76931498
rs78991728
rs111500082
rs111652552
rs112461257
rs112784269
rs112957293
rs113338664
rs114838966
rs116945031
rs117600832
rs138012748
rs138584776
rs139316333
rs139855555
rs139877430
rs140313204
rs142289207
rs142982349
rs143163933
rs144110709
rs144569657
rs145310881
rs145335491
rs145408484
rs145857665
rs145879963
rs146187043
rs146627075
rs146650989
rs147198552
rs147214773
rs147467366
rs148190725
rs148279552
rs148454403
rs149514146
rs149832756
rs150317568
rs150963196
rs180746866
rs181710622
rs181950162
rs182475452
rs183039617
rs184539659
rs184978014
rs186059305
rs187864429
rs188392595
rs189487718
rs190058515
rs191111700
rs191215962
rs192206644
rs192470654
rs199535487
rs199713103
rs200028262
rs200796213
rs200912394
rs200994803
rs201696064
rs202097184
rs368016542
rs369716820
rs371074389
rs371317659
rs372805951
rs372900959
rs374208016
rs374458307
rs374745765
rs374847203
rs375868851
rs377287446
rs527423393
rs527433948
rs528030793
rs528438664
rs528513025
rs528837403
rs528903985
rs529390227
rs529869915
rs530036047
rs530830500
rs531232368
rs531949370
rs532293495
rs533230774
rs533290861
rs533757205
rs533865173
rs535221466
rs535230481
rs535778934
rs536246055
rs536655984
rs537049589
rs537583721
rs537642531
rs538054863
rs539049812
rs539162376
rs539659155
rs539974901
rs541646907
rs541717360
rs542054261
rs542113929
rs542243727
rs542428906
rs542730277
rs543192893
rs543477821
rs544068222
rs544207403
rs544583045
rs544604524
rs544671922
rs545260075
rs545585343
rs546013875
rs546601579
rs546655844
rs546662762
rs547233134
rs547245364
rs548241326
rs548625466
rs548650567
rs548763390
rs549010240
rs549883215
rs551141629
rs551203469
rs551750691
rs553062694
rs553124006
rs553158328
rs553209234
rs553675546
rs554183912
rs554789862
rs554961770
rs555180869
rs555312759
rs556333652
rs556560104
rs556724652
rs557249467
rs557273115
rs558049223
rs559116070
rs559299522
rs559623689
rs559686336
rs559756145
rs560211223
rs560218129
rs560223240
rs561155814
rs561969013
rs562434912
rs562533333
rs563255678
rs564357587
rs564632956
rs565512037
rs565572656
rs566813397
rs567437663
rs568930464
rs568937432
rs569218923
rs569525530
rs570003758
rs570432124
rs571084269
rs571194406
rs571784467
rs571977396
rs572642853
rs572754209
rs573037333
rs573204321
rs573777404
rs573920252
rs574534464
rs575012225
rs575118384
rs575479606
rs575495658
rs575594948
rs576441901
rs576525942
rs576859955
rs577161409
rs577563030
rs745368112
rs745632311
rs746770414
rs747730832
rs747963649
rs748098105
rs748189454
rs748493255
rs748544535
rs748827835
rs748839679
rs749571357
rs749938835
rs750087956
rs750322172
rs750698397
rs750756138
rs751058742
rs751111963
rs751756723
rs751975722
rs752167988
rs752782190
rs753431695
rs753680989
rs753770848
rs753921469
rs754447450
rs754676985
rs755102336
rs755484217
rs755899324
rs756056714
rs756207760
rs756830956
rs757416006
rs757881953
rs758871604
rs759273233
rs759904341
rs759922650
rs761255687
rs761666854
rs761720005
rs761898625
rs762377247
rs762625278
rs762966305
rs763008917
rs763059810
rs763144932
rs763654353
rs764148917
rs764621696
rs764678610
rs764814850
rs765115499
rs765237875
rs765419581
rs766208541
rs766604040
rs766914563
rs767181520
rs767404285
rs767830104
rs767838620
rs768296315
rs769242131
rs769364365
rs769772228
rs770009132
rs770275656
rs770327175
rs770516483
rs770667555
rs770986091
rs771337111
rs771750319
rs771851938
rs772461295
rs772992625
rs773216142
rs774159824
rs774186681
rs774440989
rs774545896
rs775773195
rs776152740
rs776615103
rs777078340
rs777105261
rs777131342
rs777888690
rs778156449
rs778631569
rs778969048
rs779132116
rs779590491
rs779760942
rs780780627
rs781172058
rs781570700
rs781598359
正向引物序列
正向引物Tm值
反向引物序列
反向引物Tm值
rank
CTTGACACTGGATATACACTTCAG
59
AACAGGGTTCCTTCATGGAG
60
CTTGACACTGGATATACACTTCAG
59
AACAGGGTTCCTTCATGGA
59
CAGCAGGTAGCAAAGTGAC
59
TCGGTGTAGTTATCTGAAGTG
57
GCCTTACTACATTGGGATCAG
58
CCCTTGCTTGATGATTTCCAG
60
CAGCAGGTAGCAAAGTGAC
59
TTTCCTCGGTGTAGTTATCTG
57
CCCTCCTGCTGACTATTCC
59
TATCTGTCATCTGCCTCACTG
59
GCCTTACTACATTGGGATCAG
58
CCCTTGCTTGATGATTTCCA
59
CAGCAGGTAGCAAAGTGAC
59
CTCGGTGTAGTTATCTGAAGTG
58
CTTGACACTGGATATACACTTCAG
59
AAACAGGGTTCCTTCATGGA
59
基因本体信息
CXCR4基因（以及对应的蛋白质）的细胞分布位置：
- 溶酶体
- 内涵体
- 细胞核
- 细胞质
- 液泡
- 细胞膜
- 细胞外基质
- 内质网
- 线粒体
- 高尔基体
- 细胞骨架
CXCR4基因的本体（GO）信息：
GO库代码
对应的蛋白质
来源代码
GO:0000187
P61073(UniProtKB)
TAS
GO:0001618
P61073(UniProtKB)
IEA
GO:0001666
P61073(UniProtKB)
IEP
GO:0001764
P61073(UniProtKB)
IEA
GO:0002064
P61073(UniProtKB)
IEA
GO:0002407
P61073(UniProtKB)
TAS
GO:0003779
P61073(UniProtKB)
IDA
GO:0004930
P61073(UniProtKB)
TAS
GO:0005515
P61073(UniProtKB)
IPI
GO:0005515
P61073(UniProtKB)
IPI
GO:0005515
P61073(UniProtKB)
IPI
GO:0005515
P61073(UniProtKB)
IPI
GO:0005515
P61073(UniProtKB)
IPI
GO:0005515
P61073(UniProtKB)
IPI
GO:0005515
P61073(UniProtKB)
IPI
GO:0005515
P61073(UniProtKB)
IPI
GO:0005515
P61073(UniProtKB)
IPI
GO:0005515
P61073(UniProtKB)
IPI
GO:0005515
P61073(UniProtKB)
IPI
GO:0005737
P61073(UniProtKB)
TAS
GO:0005764
P61073(UniProtKB)
IDA
GO:0005769
P61073(UniProtKB)
IDA
GO:0005770
P61073(UniProtKB)
IDA
GO:0005886
P61073(UniProtKB)
IDA
GO:0005886
P61073(UniProtKB)
TAS
GO:0005886
P61073(UniProtKB)
TAS
GO:0005886
P61073(UniProtKB)
TAS
GO:0005886
P61073(UniProtKB)
TAS
GO:0005886
P61073(UniProtKB)
TAS
GO:0005886
P61073(UniProtKB)
TAS
GO:0005886
P61073(UniProtKB)
TAS
GO:0005886
P61073(UniProtKB)
TAS
GO:0005886
P61073(UniProtKB)
TAS
GO:0005886
P61073(UniProtKB)
TAS
GO:0006915
P61073(UniProtKB)
TAS
GO:0006954
P61073(UniProtKB)
TAS
GO:0007186
P61073(UniProtKB)
IDA
GO:0007204
P61073(UniProtKB)
TAS
GO:0008038
P61073(UniProtKB)
IEA
GO:0008144
P61073(UniProtKB)
IEA
GO:0009615
P61073(UniProtKB)
TAS
GO:0009986
P61073(UniProtKB)
IDA
GO:0009986
P61073(UniProtKB)
IDA
GO:0009986
P61073(UniProtKB)
IDA
GO:0009986
P61073(UniProtKB)
IDA
GO:0009986
P61073(UniProtKB)
IDA
GO:0015026
P61073(UniProtKB)
TAS
GO:0016021
P61073(UniProtKB)
IEA
GO:0016023
P61073(UniProtKB)
IDA
GO:0016494
P61073(UniProtKB)
NAS
GO:0019064
P61073(UniProtKB)
TAS
GO:0019722
P61073(UniProtKB)
IMP
GO:0019955
P61073(UniProtKB)
IEA
GO:0022029
P61073(UniProtKB)
IEA
GO:0030054
P61073(UniProtKB)
IEA
GO:0030260
P61073(UniProtKB)
TAS
GO:0030334
P61073(UniProtKB)
IEA
GO:0031252
P61073(UniProtKB)
IDA
GO:0031410
P61073(UniProtKB)
IDA
GO:0031625
P61073(UniProtKB)
IPI
GO:0032027
P61073(UniProtKB)
IDA
GO:0043067
P61073(UniProtKB)
IEA
GO:0043130
P61073(UniProtKB)
IDA
GO:0043217
P61073(UniProtKB)
ISS
GO:0048714
P61073(UniProtKB)
ISS
GO:0050920
P61073(UniProtKB)
IMP
GO:0051924
P61073(UniProtKB)
IEA
GO:0060048
P61073(UniProtKB)
IEA
GO:0070062
P61073(UniProtKB)
IDA
GO:0070098
P61073(UniProtKB)
IEA
GO:0071345
P61073(UniProtKB)
IDA
| 疾病名称 | 关系值 | NofPmids | NofSnps | 来源 |
| WHIM syndrome | 0.449771907 | 36 | 5 | BeFree_CLINVAR_CTD_human_MGD_ORPHANET |
| Neoplasm Metastasis | 0.245644501 | 238 | 1 | BeFree_CTD_human_LHGDN |
| Rheumatoid Arthritis | 0.124624443 | 9 | 0 | BeFree_CTD_human_LHGDN |
| Neoplastic Cell Transformation | 0.12 | 1 | 0 | CTD_human |
| Neuralgia | 0.12 | 1 | 0 | CTD_human |
| Juvenile arthritis | 0.12 | 2 | 0 | CTD_human |
| HIV Infections | 0.094916828 | 327 | 0 | BeFree_GAD_LHGDN |
| Mammary Neoplasms | 0.040855322 | 23 | 0 | BeFree_LHGDN |
| Prostatic Neoplasms | 0.031325062 | 15 | 0 | BeFree_LHGDN |
| Malignant neoplasm of breast | 0.028968335 | 98 | 5 | BeFree_GAD |
| Squamous cell carcinoma | 0.027147695 | 18 | 0 | BeFree_GAD_LHGDN |
| Breast Carcinoma | 0.026329862 | 97 | 5 | BeFree |
| melanoma | 0.023684964 | 21 | 1 | BeFree_LHGDN |
| Lung Neoplasms | 0.022337686 | 10 | 0 | BeFree_LHGDN |
| Glioma | 0.016869122 | 25 | 0 | BeFree_LHGDN |
| Infection | 0.013621751 | 5 | 0 | LHGDN |
| Pancreatic Neoplasm | 0.01225461 | 9 | 0 | BeFree_LHGDN |
| Colorectal Neoplasms | 0.011440285 | 6 | 0 | BeFree_LHGDN |
| Osteosarcoma | 0.010887469 | 11 | 0 | BeFree_LHGDN |
| Chronic Lymphocytic Leukemia | 0.010444275 | 13 | 0 | BeFree_GAD_LHGDN |
| Primary Myelofibrosis | 0.009801702 | 7 | 2 | BeFree_LHGDN |
| Colorectal Cancer | 0.009695963 | 28 | 0 | BeFree_GAD |
| leukemia | 0.009520329 | 15 | 0 | BeFree_LHGDN |
| Liver carcinoma | 0.009444384 | 7 | 0 | BeFree_GAD_LHGDN |
| Rhabdomyosarcoma | 0.008987376 | 5 | 0 | BeFree_LHGDN |
| Leukemia, Myelocytic, Acute | 0.008967513 | 24 | 0 | BeFree_LHGDN |
| Stomach Neoplasms | 0.008715934 | 5 | 0 | BeFree_LHGDN |
| Thyroid Neoplasm | 0.008715934 | 5 | 0 | BeFree_LHGDN |
| Colorectal Carcinoma | 0.008143256 | 30 | 0 | BeFree |
| Malignant neoplasm of pancreas | 0.008143256 | 30 | 0 | BeFree |
| Malignant neoplasm of prostate | 0.008143256 | 30 | 0 | BeFree |
| Neuroblastoma | 0.008077243 | 13 | 3 | BeFree_GAD_LHGDN |
| Tumor Progression | 0.007871814 | 29 | 1 | BeFree |
| Prostate carcinoma | 0.007871814 | 29 | 0 | BeFree |
| Secondary malignant neoplasm of lymph node | 0.007871814 | 29 | 0 | BeFree |
| Pancreatic carcinoma | 0.007328931 | 27 | 0 | BeFree |
| Precursor Cell Lymphoblastic Leukemia Lymphoma | 0.007077352 | 7 | 0 | BeFree_LHGDN |
| Glioblastoma | 0.006524536 | 15 | 0 | BeFree_LHGDN |
| Adenocarcinoma | 0.006263026 | 4 | 0 | BeFree_LHGDN |
| Waldenstrom Macroglobulinemia | 0.005981653 | 12 | 2 | BeFree_LHGDN |
| Multiple Myeloma | 0.005971721 | 22 | 0 | BeFree |
| Ovarian Carcinoma | 0.005971721 | 22 | 0 | BeFree |
| Systemic Scleroderma | 0.005720142 | 2 | 0 | BeFree_LHGDN |
| Asthma | 0.005276948 | 4 | 0 | BeFree_GAD |
| Multiple Sclerosis | 0.005276948 | 4 | 1 | BeFree_GAD |
| Malignant neoplasm of ovary | 0.005157396 | 19 | 0 | BeFree |
| Diabetes Mellitus, Non-Insulin-Dependent | 0.005005506 | 2 | 0 | BeFree_GAD |
| Brain Neoplasms | 0.004624443 | 7 | 0 | BeFree_LHGDN |
| Secondary malignant neoplasm of liver | 0.00434307 | 16 | 0 | BeFree |
| Stomach Carcinoma | 0.00434307 | 16 | 0 | BeFree |
| Malignant neoplasm of stomach | 0.004071628 | 15 | 0 | BeFree |
| Carcinogenesis | 0.004071628 | 15 | 0 | BeFree |
| Adenoid Cystic Carcinoma | 0.003810118 | 4 | 0 | BeFree_LHGDN |
| Lupus Erythematosus, Systemic | 0.003810118 | 4 | 0 | BeFree_LHGDN |
| Medulloblastoma | 0.003810118 | 4 | 0 | BeFree_LHGDN |
| Colon Carcinoma | 0.003800186 | 14 | 1 | BeFree |
| Arthritis | 0.003538676 | 4 | 0 | BeFree_LHGDN |
| Hemangioblastoma | 0.003538676 | 3 | 0 | BeFree_LHGDN |
| Sarcoma | 0.003538676 | 4 | 0 | BeFree_LHGDN |
| Malignant tumor of colon | 0.003528744 | 13 | 1 | BeFree |
| Acquired Immunodeficiency Syndrome | 0.003267234 | 3 | 0 | BeFree_LHGDN |
| Bladder Neoplasm | 0.003267234 | 2 | 0 | BeFree_LHGDN |
| Cholangiocarcinoma | 0.003267234 | 2 | 0 | BeFree_LHGDN |
| Non-Small Cell Lung Carcinoma | 0.003257302 | 12 | 0 | BeFree |
| Lymphatic Metastasis | 0.003181358 | 4 | 0 | BeFree_GAD |
| AIDS Dementia Complex | 0.002995792 | 2 | 0 | BeFree_LHGDN |
| Noninfiltrating Intraductal Carcinoma | 0.002995792 | 1 | 0 | BeFree_LHGDN |
| Lymphoma, Follicular | 0.002995792 | 1 | 0 | BeFree_LHGDN |
| Pituitary Neoplasms | 0.002995792 | 2 | 0 | BeFree_LHGDN |
| Tuberculosis, Pulmonary | 0.002995792 | 1 | 0 | BeFree_LHGDN |
| Renal Cell Carcinoma | 0.002985861 | 11 | 0 | BeFree |
| Secondary malignant neoplasm of bone | 0.002985861 | 11 | 0 | BeFree |
| Central neuroblastoma | 0.002985861 | 11 | 0 | BeFree |
| Liver neoplasms | 0.002909916 | 3 | 0 | BeFree_GAD |
| Anoxia | 0.00272435 | 1 | 0 | LHGDN |
| Hyperplasia | 0.00272435 | 1 | 0 | LHGDN |
| Kidney Neoplasm | 0.00272435 | 1 | 0 | LHGDN |
| Lung diseases | 0.00272435 | 1 | 0 | LHGDN |
| Myositis | 0.00272435 | 1 | 0 | LHGDN |
| Liver Failure | 0.00272435 | 1 | 0 | LHGDN |
| Rhabdomyosarcoma, Embryonal | 0.00272435 | 1 | 0 | LHGDN |
| Disease Progression | 0.00272435 | 1 | 0 | LHGDN |
| Immunologic Deficiency Syndromes | 0.002714419 | 10 | 0 | BeFree |
| Secondary malignant neoplasm of lung | 0.002714419 | 10 | 0 | BeFree |
| Papillary thyroid carcinoma | 0.002714419 | 10 | 0 | BeFree |
| Osteosarcoma of bone | 0.002714419 | 10 | 0 | BeFree |
| Myelokathexis | 0.002442977 | 9 | 1 | BeFree |
| Coronary heart disease | 0.002367032 | 1 | 0 | GAD |
| Lymphoma, Non-Hodgkin | 0.002367032 | 1 | 0 | GAD |
| Mouth Neoplasms | 0.002367032 | 1 | 0 | GAD |
| HIV disease progression | 0.002367032 | 1 | 0 | GAD |
| Acute lymphocytic leukemia | 0.002171535 | 8 | 0 | BeFree |
| Lymphoma | 0.002171535 | 8 | 0 | BeFree |
| Malignant neoplasm of lung | 0.002171535 | 8 | 0 | BeFree |
| Cervix carcinoma | 0.002171535 | 8 | 0 | BeFree |
| Epithelial ovarian cancer | 0.002171535 | 8 | 0 | BeFree |
| Astrocytoma | 0.001900093 | 7 | 0 | BeFree |
| Virus Diseases | 0.001900093 | 7 | 0 | BeFree |
| Carcinoma of lung | 0.001900093 | 7 | 0 | BeFree |
| Malignant neoplasm of kidney | 0.001900093 | 7 | 0 | BeFree |
| Renal carcinoma | 0.001900093 | 7 | 0 | BeFree |
| Malignant neoplasm of urinary bladder | 0.001628651 | 6 | 1 | BeFree |
| Malignant tumor of cervix | 0.001628651 | 6 | 0 | BeFree |
| Ischemia | 0.001628651 | 6 | 0 | BeFree |
| Myeloid Leukemia, Chronic | 0.001628651 | 6 | 0 | BeFree |
| Severe Combined Immunodeficiency | 0.001628651 | 6 | 0 | BeFree |
| Malignant neoplasm of mouth | 0.001628651 | 6 | 0 | BeFree |
| Lip and Oral Cavity Carcinoma | 0.001628651 | 6 | 0 | BeFree |
| Carcinoma of bladder | 0.001628651 | 6 | 1 | BeFree |
| Squamous cell carcinoma of the head and neck | 0.001628651 | 6 | 0 | BeFree |
| Xenograft Model | 0.001628651 | 6 | 0 | BeFree |
| Leukopenia | 0.001357209 | 5 | 0 | BeFree |
| Esophageal carcinoma | 0.001357209 | 5 | 0 | BeFree |
| Carcinoma breast stage IV | 0.001357209 | 5 | 0 | BeFree |
| Non-Malignant Ascites Adverse Event | 0.001357209 | 5 | 0 | BeFree |
| Idiopathic Pulmonary Fibrosis | 0.001357209 | 5 | 0 | BeFree |
| Nasopharyngeal carcinoma | 0.001357209 | 5 | 0 | BeFree |
| Inflammatory Bowel Diseases | 0.001085767 | 4 | 0 | BeFree |
| Pituitary Diseases | 0.001085767 | 4 | 0 | BeFree |
| Diffuse Large B-Cell Lymphoma | 0.001085767 | 4 | 0 | BeFree |
| Small cell carcinoma of lung | 0.001085767 | 4 | 0 | BeFree |
| Agenesis of corpus callosum | 0.001085767 | 4 | 0 | BeFree |
| Uveal melanoma | 0.001085767 | 4 | 0 | BeFree |
| Solid tumour | 0.001085767 | 4 | 0 | BeFree |
| Ewings sarcoma | 0.001085767 | 4 | 0 | BeFree |
| Triple Negative Breast Neoplasms | 0.001085767 | 4 | 0 | BeFree |
| Arteriosclerosis | 0.000814326 | 3 | 0 | BeFree |
| Atherosclerosis | 0.000814326 | 3 | 0 | BeFree |
| Chondrosarcoma | 0.000814326 | 3 | 0 | BeFree |
| Endometriosis | 0.000814326 | 3 | 0 | BeFree |
| Von Hippel-Lindau Syndrome | 0.000814326 | 3 | 0 | BeFree |
| Immune System Diseases | 0.000814326 | 3 | 0 | BeFree |
| Myelofibrosis | 0.000814326 | 3 | 0 | BeFree |
| Neutropenia | 0.000814326 | 3 | 0 | BeFree |
| Degenerative polyarthritis | 0.000814326 | 3 | 0 | BeFree |
| Pituitary Adenoma | 0.000814326 | 3 | 0 | BeFree |
| Pulmonary Fibrosis | 0.000814326 | 3 | 0 | BeFree |
| Cerebrovascular accident | 0.000814326 | 3 | 0 | BeFree |
| Superinfection | 0.000814326 | 3 | 0 | BeFree |
| Squamous cell carcinoma of esophagus | 0.000814326 | 3 | 0 | BeFree |
| Adenocarcinoma of pancreas | 0.000814326 | 3 | 0 | BeFree |
| Primary immune deficiency disorder | 0.000814326 | 3 | 0 | BeFree |
| Thyroid carcinoma | 0.000814326 | 3 | 0 | BeFree |
| Leukemogenesis | 0.000814326 | 3 | 0 | BeFree |
| Metastatic Prostate Carcinoma | 0.000814326 | 3 | 0 | BeFree |
| Primary infection NOS | 0.000814326 | 3 | 0 | BeFree |
| Precursor B-cell lymphoblastic leukemia | 0.000814326 | 3 | 0 | BeFree |
| Tumor Angiogenesis | 0.000814326 | 3 | 0 | BeFree |
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 0.000814326 | 3 | 0 | BeFree |
| Experimental Organism Basal Cell Carcinoma | 0.000814326 | 3 | 0 | BeFree |
| Alzheimer's Disease | 0.000542884 | 2 | 0 | BeFree |
| Ulcerative Colitis | 0.000542884 | 2 | 0 | BeFree |
| Presenile dementia | 0.000542884 | 2 | 0 | BeFree |
| Esophageal Neoplasms | 0.000542884 | 2 | 0 | BeFree |
| Graves Disease | 0.000542884 | 2 | 0 | BeFree |
| nervous system disorder | 0.000542884 | 2 | 0 | BeFree |
| polyps | 0.000542884 | 2 | 0 | BeFree |
| Vascular Diseases | 0.000542884 | 2 | 0 | BeFree |
| B-Cell Lymphomas | 0.000542884 | 2 | 1 | BeFree |
| Synovial Cyst | 0.000542884 | 2 | 0 | BeFree |
| Cutaneous Melanoma | 0.000542884 | 2 | 0 | BeFree |
| Mucoepidermoid Carcinoma | 0.000542884 | 2 | 0 | BeFree |
| Adult Acute Myeloblastic Leukemia | 0.000542884 | 2 | 0 | BeFree |
| Metastatic malignant neoplasm to brain | 0.000542884 | 2 | 0 | BeFree |
| Anaplastic thyroid carcinoma | 0.000542884 | 2 | 0 | BeFree |
| Sepsis | 0.000542884 | 2 | 0 | BeFree |
| Malignant neoplasm of stomach stage IV | 0.000542884 | 2 | 0 | BeFree |
| Conventional (Clear Cell) Renal Cell Carcinoma | 0.000542884 | 2 | 0 | BeFree |
| Tumor necrosis | 0.000542884 | 2 | 0 | BeFree |
| Malignant lymphoma - lymphoplasmacytic | 0.000542884 | 2 | 1 | BeFree |
| Congenital neutropenia | 0.000542884 | 2 | 0 | BeFree |
| Human immunodeficiency virus, type 2 [HIV-2] infection in conditions classified elsewhere and of unspecified site | 0.000542884 | 2 | 0 | BeFree |
| Hematologic Neoplasms | 0.000542884 | 2 | 0 | BeFree |
| Endometrial Carcinoma | 0.000542884 | 2 | 0 | BeFree |
| Dementia | 0.000542884 | 2 | 0 | BeFree |
| Recurrent tumor | 0.000542884 | 2 | 0 | BeFree |
| Malignant neoplasm of esophagus | 0.000542884 | 2 | 0 | BeFree |
| Malignant Glioma | 0.000542884 | 2 | 0 | BeFree |
| invasive cancer | 0.000542884 | 2 | 0 | BeFree |
| Thrombocytosis | 0.000542884 | 2 | 0 | BeFree |
| cancer recurrence | 0.000542884 | 2 | 0 | BeFree |
| Myxoid cyst | 0.000542884 | 2 | 0 | BeFree |
| Tumor Expansion | 0.000542884 | 2 | 0 | BeFree |
| Glioblastoma Multiforme | 0.000542884 | 2 | 0 | BeFree |
| Recurrent infections (sinusitis and bacterial pneumonia and meningitis) | 0.000542884 | 2 | 0 | BeFree |
| Severe congenital neutropenia | 0.000542884 | 2 | 0 | BeFree |
| Adenoma | 0.000271442 | 1 | 0 | BeFree |
| Aplastic Anemia | 0.000271442 | 1 | 0 | BeFree |
| Angina, Unstable | 0.000271442 | 1 | 0 | BeFree |
| Autoimmune Diseases | 0.000271442 | 1 | 0 | BeFree |
| Bacterial Infections | 0.000271442 | 1 | 0 | BeFree |
| Bipolar Disorder | 0.000271442 | 1 | 0 | BeFree |
| Blast Phase | 0.000271442 | 1 | 0 | BeFree |
| Bone Diseases | 0.000271442 | 1 | 0 | BeFree |
| Bone neoplasms | 0.000271442 | 1 | 0 | BeFree |
| Brain Diseases | 0.000271442 | 1 | 0 | BeFree |
| Breast Diseases | 0.000271442 | 1 | 0 | BeFree |
| Bronchiolitis Obliterans | 0.000271442 | 1 | 0 | BeFree |
| Female Breast Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Rectal Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Malignant neoplasm of thyroid | 0.000271442 | 1 | 0 | BeFree |
| Cerebral Infarction | 0.000271442 | 1 | 0 | BeFree |
| Choriocarcinoma | 0.000271442 | 1 | 0 | BeFree |
| Colonic Polyps | 0.000271442 | 1 | 0 | BeFree |
| Craniopharyngioma | 0.000271442 | 1 | 0 | BeFree |
| Phyllodes Tumor | 0.000271442 | 1 | 0 | BeFree |
| Diabetes | 0.000271442 | 1 | 0 | BeFree |
| Diabetes Mellitus | 0.000271442 | 1 | 0 | BeFree |
| Diabetic Nephropathy | 0.000271442 | 1 | 0 | BeFree |
| Drug abuse | 0.000271442 | 1 | 0 | BeFree |
| Experimental Autoimmune Encephalomyelitis | 0.000271442 | 1 | 0 | BeFree |
| Fanconi Anemia | 0.000271442 | 1 | 0 | BeFree |
| Breast Fibrocystic Disease | 0.000271442 | 1 | 0 | BeFree |
| Gastrointestinal Neoplasms | 0.000271442 | 1 | 0 | BeFree |
| Gingival Diseases | 0.000271442 | 1 | 0 | BeFree |
| Hematological Disease | 0.000271442 | 1 | 0 | BeFree |
| Hemolytic-Uremic Syndrome | 0.000271442 | 1 | 0 | BeFree |
| Hepatitis, Alcoholic | 0.000271442 | 1 | 0 | BeFree |
| Herpes Simplex Infections | 0.000271442 | 1 | 0 | BeFree |
| Kidney Failure, Acute | 0.000271442 | 1 | 0 | BeFree |
| Acute Erythroblastic Leukemia | 0.000271442 | 1 | 0 | BeFree |
| Lymphoid leukemia | 0.000271442 | 1 | 0 | BeFree |
| Myeloid Leukemia | 0.000271442 | 1 | 0 | BeFree |
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 0.000271442 | 1 | 0 | BeFree |
| Leukemia, T-Cell | 0.000271442 | 1 | 0 | BeFree |
| Adult T-Cell Lymphoma/Leukemia | 0.000271442 | 1 | 0 | BeFree |
| Liver diseases | 0.000271442 | 1 | 0 | BeFree |
| Lymphopenia | 0.000271442 | 1 | 0 | BeFree |
| Multiple Endocrine Neoplasia Type 2b | 0.000271442 | 1 | 1 | BeFree |
| Meningioma | 0.000271442 | 1 | 0 | BeFree |
| Monoclonal Gammopathy of Undetermined Significance | 0.000271442 | 1 | 0 | BeFree |
| Mycobacterium avium-intracellulare Infection | 0.000271442 | 1 | 0 | BeFree |
| Multiple Endocrine Neoplasia | 0.000271442 | 1 | 1 | BeFree |
| Obesity | 0.000271442 | 1 | 0 | BeFree |
| Opportunistic Infections | 0.000271442 | 1 | 0 | BeFree |
| Periodontal Diseases | 0.000271442 | 1 | 0 | BeFree |
| Pneumonia | 0.000271442 | 1 | 0 | BeFree |
| Prolactinoma | 0.000271442 | 1 | 0 | BeFree |
| Pterygium | 0.000271442 | 1 | 0 | BeFree |
| Sarcoidosis | 0.000271442 | 1 | 0 | BeFree |
| Septicemia | 0.000271442 | 1 | 0 | BeFree |
| synovial sarcoma | 0.000271442 | 1 | 0 | BeFree |
| Thrombocythemia, Essential | 0.000271442 | 1 | 0 | BeFree |
| Thyroiditis | 0.000271442 | 1 | 0 | BeFree |
| Tuberculosis | 0.000271442 | 1 | 0 | BeFree |
| Uveitis | 0.000271442 | 1 | 0 | BeFree |
| T-Cell Lymphoma | 0.000271442 | 1 | 0 | BeFree |
| Lymphoma, T-Cell, Cutaneous | 0.000271442 | 1 | 0 | BeFree |
| Polyendocrinopathies, Autoimmune | 0.000271442 | 1 | 0 | BeFree |
| Acute leukemia | 0.000271442 | 1 | 0 | BeFree |
| Hamman-Rich syndrome | 0.000271442 | 1 | 0 | BeFree |
| Hypogammaglobulinemia | 0.000271442 | 1 | 0 | BeFree |
| Epstein-Barr Virus Infections | 0.000271442 | 1 | 0 | BeFree |
| Genital ulceration | 0.000271442 | 1 | 0 | BeFree |
| Thyroid Gland Follicular Adenoma | 0.000271442 | 1 | 0 | BeFree |
| Congenital heart disease | 0.000271442 | 1 | 0 | BeFree |
| Idiopathic pulmonary hypertension | 0.000271442 | 1 | 0 | BeFree |
| Secondary malignant neoplasm of kidney | 0.000271442 | 1 | 0 | BeFree |
| Acute myocardial infarction | 0.000271442 | 1 | 0 | BeFree |
| Chronic obstructive asthma (with obstructive pulmonary disease) | 0.000271442 | 1 | 0 | BeFree |
| Malnutrition | 0.000271442 | 1 | 0 | BeFree |
| Cicatrix, Hypertrophic | 0.000271442 | 1 | 0 | BeFree |
| Aortic Aneurysm, Abdominal | 0.000271442 | 1 | 0 | BeFree |
| pediatric acute myeloblastic leukemia | 0.000271442 | 1 | 0 | BeFree |
| Malignant neoplasm of salivary gland | 0.000271442 | 1 | 0 | BeFree |
| Hyperviscosity syndrome | 0.000271442 | 1 | 1 | BeFree |
| Malignant neoplasm of female breast | 0.000271442 | 1 | 0 | BeFree |
| Gallbladder Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Hereditary pancreatitis | 0.000271442 | 1 | 0 | BeFree |
| Desquamative interstitial pneumonia | 0.000271442 | 1 | 0 | BeFree |
| Medullary carcinoma of thyroid | 0.000271442 | 1 | 1 | BeFree |
| Interstitial fibrosis | 0.000271442 | 1 | 0 | BeFree |
| Hepatitis, Autoimmune | 0.000271442 | 1 | 0 | BeFree |
| Psoriasiform eczema | 0.000271442 | 1 | 0 | BeFree |
| Epithelial hyperplasia of skin | 0.000271442 | 1 | 0 | BeFree |
| Chronic heart failure | 0.000271442 | 1 | 0 | BeFree |
| Impaired glucose tolerance | 0.000271442 | 1 | 0 | BeFree |
| Acquired aplastic anemia | 0.000271442 | 1 | 0 | BeFree |
| Coinfection | 0.000271442 | 1 | 0 | BeFree |
| Inflammatory Breast Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Stage IV Ovarian Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Gastric Adenocarcinoma | 0.000271442 | 1 | 0 | BeFree |
| Metastatic melanoma | 0.000271442 | 1 | 0 | BeFree |
| Non-small cell lung cancer metastatic | 0.000271442 | 1 | 0 | BeFree |
| Squamous cell carcinoma of the hypopharynx | 0.000271442 | 1 | 0 | BeFree |
| Intraocular Lymphoma | 0.000271442 | 1 | 0 | BeFree |
| Vascular Neoplasms | 0.000271442 | 1 | 0 | BeFree |
| Bone Marrow Neoplasms | 0.000271442 | 1 | 0 | BeFree |
| Healing ulcer | 0.000271442 | 1 | 0 | BeFree |
| Stable angina | 0.000271442 | 1 | 0 | BeFree |
| Intrahepatic Cholangiocarcinoma | 0.000271442 | 1 | 0 | BeFree |
| Malignant mesothelioma | 0.000271442 | 1 | 0 | BeFree |
| Growth Hormone-Secreting Pituitary Adenoma | 0.000271442 | 1 | 0 | BeFree |
| Multiple malignancy | 0.000271442 | 1 | 0 | BeFree |
| Intestinal Cancer | 0.000271442 | 1 | 0 | BeFree |
| Secondary malignant neoplasm of prostate | 0.000271442 | 1 | 0 | BeFree |
| Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site | 0.000271442 | 1 | 0 | BeFree |
| Overweight | 0.000271442 | 1 | 0 | BeFree |
| Squamous cell carcinoma of mouth | 0.000271442 | 1 | 0 | BeFree |
| Aqueous Humor Disorders | 0.000271442 | 1 | 0 | BeFree |
| Refractory cancer | 0.000271442 | 1 | 0 | BeFree |
| Sentinel node (disorder) | 0.000271442 | 1 | 0 | BeFree |
| Malignant neoplasm of gastrointestinal tract | 0.000271442 | 1 | 0 | BeFree |
| airway disease | 0.000271442 | 1 | 0 | BeFree |
| Chronic neutropenia | 0.000271442 | 1 | 0 | BeFree |
| Idiopathic Inflammatory Myopathies | 0.000271442 | 1 | 0 | BeFree |
| Malignant Pleural Mesothelioma | 0.000271442 | 1 | 0 | BeFree |
| Immunodeficiency congenital | 0.000271442 | 1 | 0 | BeFree |
| Invasive breast carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Rhabdoid Tumor of the Kidney | 0.000271442 | 1 | 0 | BeFree |
| Infectious disease of lung | 0.000271442 | 1 | 0 | BeFree |
| Cerebral Ischemia | 0.000271442 | 1 | 0 | BeFree |
| Renal cancer metastatic | 0.000271442 | 1 | 0 | BeFree |
| Ovarian adenocarcinoma | 0.000271442 | 1 | 0 | BeFree |
| Invasive Ductal Breast Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Endometrial adenocarcinoma | 0.000271442 | 1 | 0 | BeFree |
| Ductal Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Mammary Carcinoma, Human | 0.000271442 | 1 | 0 | BeFree |
| Morphologically altered structure | 0.000271442 | 1 | 0 | BeFree |
| Lymphocytic infiltration | 0.000271442 | 1 | 0 | BeFree |
| Chronic myeloproliferative disorder | 0.000271442 | 1 | 0 | BeFree |
| Pancreatic intraepithelial neoplasia | 0.000271442 | 1 | 0 | BeFree |
| Precursor T cell lymphoblastic leukemia/lymphoblastic lymphoma | 0.000271442 | 1 | 0 | BeFree |
| Atypical Ductal Breast Hyperplasia | 0.000271442 | 1 | 0 | BeFree |
| Gastric Mucosa-Associated Lymphoid Tissue Lymphoma | 0.000271442 | 1 | 0 | BeFree |
| Invasive Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Neuroblastic Tumor | 0.000271442 | 1 | 0 | BeFree |
| Conventional Chondrosarcoma | 0.000271442 | 1 | 0 | BeFree |
| Mucoepidermoid carcinoma of salivary gland | 0.000271442 | 1 | 0 | BeFree |
| Sporadic Breast Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Differentiated Thyroid Gland Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Cardiomyopathy, Familial Idiopathic | 0.000271442 | 1 | 0 | BeFree |
| Hereditary Melanoma | 0.000271442 | 1 | 0 | BeFree |
| Neuropathogenesis | 0.000271442 | 1 | 0 | BeFree |
| Pneumocystis jiroveci pneumonia | 0.000271442 | 1 | 0 | BeFree |
| Chronic Kidney Diseases | 0.000271442 | 1 | 0 | BeFree |
| Adenocarcinoma, Endometrioid | 0.000271442 | 1 | 0 | BeFree |
| tumor vasculature | 0.000271442 | 1 | 0 | BeFree |
| Secondary Focal Segmental Glomerulosclerosis | 0.000271442 | 1 | 0 | BeFree |
| Painful Bladder Syndrome | 0.000271442 | 1 | 0 | BeFree |
| Meningioma, benign, no ICD-O subtype | 0.000271442 | 1 | 0 | BeFree |
| Allergic rhinitis (disorder) | 0.000271442 | 1 | 0 | BeFree |
| Combined immunodeficiency disease | 0.000271442 | 1 | 0 | BeFree |
| Clear-cell metastatic renal cell carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Pulmonary arterial hypertension | 0.000271442 | 1 | 0 | BeFree |
| FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) | 0.000271442 | 1 | 0 | BeFree |
| Micropapillary carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Pulmonary Hypertension, Primary, 1, With Hereditary Hemorrhagic Telangiectasia | 0.000271442 | 1 | 0 | BeFree |
| Cytogenetically normal acute myeloid leukemia | 0.000271442 | 1 | 0 | BeFree |
登陆
忘记密码? 点击找回密码.
